UnitedHealth Group Inc (NYSE:UNH) Shares Acquired by Stewart & Patten Co. LLC

Stewart & Patten Co. LLC grew its position in UnitedHealth Group Inc (NYSE:UNH) by 4.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 38,733 shares of the healthcare conglomerate’s stock after purchasing an additional 1,794 shares during the period. UnitedHealth Group makes up 1.5% of Stewart & Patten Co. LLC’s holdings, making the stock its 26th largest position. Stewart & Patten Co. LLC’s holdings in UnitedHealth Group were worth $8,417,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Eastern Bank boosted its stake in shares of UnitedHealth Group by 2.0% in the second quarter. Eastern Bank now owns 69,088 shares of the healthcare conglomerate’s stock worth $16,858,000 after buying an additional 1,375 shares during the last quarter. Capital Investment Advisors LLC boosted its stake in shares of UnitedHealth Group by 26.2% in the second quarter. Capital Investment Advisors LLC now owns 6,379 shares of the healthcare conglomerate’s stock worth $1,556,000 after buying an additional 1,323 shares during the last quarter. Berkeley Capital Partners LLC boosted its stake in shares of UnitedHealth Group by 7.4% in the second quarter. Berkeley Capital Partners LLC now owns 2,220 shares of the healthcare conglomerate’s stock worth $542,000 after buying an additional 153 shares during the last quarter. Calton & Associates Inc. boosted its stake in shares of UnitedHealth Group by 22.7% in the second quarter. Calton & Associates Inc. now owns 2,074 shares of the healthcare conglomerate’s stock worth $506,000 after buying an additional 384 shares during the last quarter. Finally, Granite Investment Partners LLC boosted its stake in shares of UnitedHealth Group by 1.8% in the second quarter. Granite Investment Partners LLC now owns 67,540 shares of the healthcare conglomerate’s stock worth $16,480,000 after buying an additional 1,193 shares during the last quarter. 85.71% of the stock is currently owned by institutional investors and hedge funds.

UNH has been the topic of a number of recent research reports. Credit Suisse Group set a $293.00 target price on UnitedHealth Group and gave the stock a “buy” rating in a research note on Thursday, August 29th. Oppenheimer set a $312.00 target price on UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. Royal Bank of Canada set a $311.00 target price on UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. Jefferies Financial Group downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and lowered their target price for the stock from $300.00 to $235.00 in a research note on Thursday, October 10th. Finally, Barclays set a $260.00 target price on UnitedHealth Group and gave the stock a “buy” rating in a research note on Tuesday, October 8th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $284.61.

In other news, Director William C. Ballard, Jr. sold 12,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total value of $3,063,720.00. Following the transaction, the director now owns 61,309 shares in the company, valued at $15,652,800.79. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction that occurred on Thursday, September 19th. The shares were sold at an average price of $233.40, for a total value of $583,500.00. Following the completion of the transaction, the director now owns 187,979 shares in the company, valued at approximately $43,874,298.60. The disclosure for this sale can be found here. Insiders have sold 24,000 shares of company stock worth $5,924,120 in the last quarter. 0.87% of the stock is currently owned by company insiders.

UNH stock traded up $3.82 during mid-day trading on Thursday, reaching $240.81. 2,055,724 shares of the company’s stock were exchanged, compared to its average volume of 4,751,349. The company has a market cap of $209.05 billion, a price-to-earnings ratio of 18.70, a price-to-earnings-growth ratio of 1.18 and a beta of 0.60. The stock’s 50 day moving average is $226.77 and its 200 day moving average is $239.68. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.67 and a quick ratio of 0.67. UnitedHealth Group Inc has a 12-month low of $208.07 and a 12-month high of $287.94.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.75 by $0.13. The company had revenue of $60.35 billion for the quarter, compared to the consensus estimate of $59.84 billion. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. UnitedHealth Group’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.41 earnings per share. On average, research analysts forecast that UnitedHealth Group Inc will post 14.91 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a dividend of $1.08 per share. The ex-dividend date of this dividend was Friday, September 13th. This represents a $4.32 dividend on an annualized basis and a yield of 1.79%. UnitedHealth Group’s dividend payout ratio is currently 33.54%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: What is the definition of market timing?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.